- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/37 - Factors VIII
Patent holdings for IPC class A61K 38/37
Total number of patents in this class: 663
10-year publication summary
|
54
|
44
|
42
|
48
|
51
|
34
|
30
|
31
|
35
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bioverativ Therapeutics Inc. | 214 |
60 |
| Takeda Pharmaceutical Company Limited | 2706 |
37 |
| The Children's Hospital of Philadelphia | 803 |
22 |
| CSL Behring GmbH | 343 |
16 |
| CSL Limited | 255 |
16 |
| CSL Behring Lengnau AG | 126 |
16 |
| Octapharma AG | 203 |
15 |
| St. Jude Children's Research Hospital | 242 |
15 |
| Cantab Biopharmaceuticals Patents Limited | 23 |
14 |
| Novo Nordisk A/S | 2273 |
14 |
| BioMarin Pharmaceutical Inc. | 375 |
12 |
| Quiapeg Pharmaceuticals AB | 45 |
12 |
| Rani Therapeutics, LLC | 200 |
11 |
| Spark Therapeutics, Inc. | 170 |
11 |
| UCL Business Ltd | 622 |
11 |
| Baxalta Incorporated | 304 |
10 |
| Sangamo Therapeutics, Inc. | 422 |
10 |
| Baxalta GmbH | 104 |
8 |
| Biotest AG | 112 |
8 |
| Selecta Biosciences, Inc. | 189 |
8 |
| Other owners | 337 |